Introduction
Tympanic membrane (TM) perforations after trauma or infection are not uncommon. Most will heal spontaneously within two to six weeks. However, in some cases, perforation closure fails to occur and intervention may become necessary. Recent wound healing research has dealt with topical application of various agents, such as peptide growth factors, to promote wound healing. Basic fibroblast growth factor (bFGF) is currently being investigated in this regard. Basic FGF promotes the production of extracellular matrix and stimulates migration and proliferation of kcratinocytcs and fibrobla sts.!" It therefore has the potential to affect major components of the TM. Application of bFGF to traumatic perforations has been reported to promote not only healing but also hyperplasia of the connective tissue within the lamina propria in areas of the TM away from the injury.l" On the other hand, when bFGF is applied to normal tympanic membranes it tends to primarily stimulate epidermal hyperplasia, with less dramarie effects on connective tissue of the lamina propria," The difference in response between intact and perforated tympanic membranes suggests that injur y or inflammation may be necessary to stimulate the connective tissue response to bFGF. It has been hypothesized that connective tissue hyperplasia may be increased by upregulation of bFGF receptors in the presence of intlammation/injury or that the injury may stimulate release of other growth factors capable of potentiating the effect of bFGFY Animal studies have shown that injury and/or inflarnmation are associated with epidermal and connective tissue hyperplasia of the TM and that middle car cholesteatoma may form by ingrowth of epidermis through the hyperplastic connective tissue of the lamina propria.!" Given the demonstrated effects of bFGF on the tympanic membrane, the possibility exists that it might play a role in the pathogenesis of this type ofcholesteatoma. In previous studies on application of bFGF to tympanic membrane perforations, there have been no reports of cholesteatoma formation. However, the survival periods have typically been too short to adequately address this issue. The possibility that bFGF might stimulate ingrowth of skin to the middle car therefore needs further study before the growth factor can be considered for clinical usc in the treatment of tympanic membrane perforations.
This investigation was performed to evaluate the hyperplastic effects of bFGF on perforated chinchilla tympanic membranes at survival times of lip to four weeks: A primary objec tive was to determine if bFGF might facilitate cholesteatoma formation.
Methods
Ten adult chinchillas were included in this investigation and were treated in accordance with National Institutes of Health guidelines for the care and lise of laboratory animals. After induction of kcraminc/xylazinc anesthesia, an operating microscope was used to visualize the tympanic membrane and verify that it appeared normal. A sterile 18gauge needle was then used to make a perforation in the anterior/superior portion of the TM. Four-hundred nanogramsoffreshly reconstituted bFGF (Gibco, Gaithersberg, MD) in 40 microliters of sterile saline were applied to the In an additional eight ears, closure time estimates were possible and subsequent histology confirmed that complete closure occurred by the time the animals were sacrificed. The apparent times to closure were variable, ranging from six to 18 days, although in six of the eight ears the perforations appeared to heal within eight to 12 days. In this group, there was a trend toward earlier closure in the ears that received bFGF. However, this finding is compromised by the fact that judgments regarding the date of closure were not always accurate, as noted above.
Results
In this study, it did not prove possible to reliably determine the time of perforation clo sure by operating microscope observation of the lateral aspect of the chinchilla TM. Eight of the 20 ears developed sizable accumulations of keratin overlying the perforation site before healing was complete. In these cases, a clear view of the tympanic membrane surface could not be obtained, making it impos sible to document the exact date of closure. Since the keratinous crusts covering the perforation site s tended to adhere to the TM surface, we elected not to remove them so as not to disturb the healing process. It was subsequently found that four of the eight ears in this group had histologically open perforations at either two or four weeks ( Figure I ). Keratin crusts developed at the site of perforation with equal frequency in the control and bFGF-treated ears.
In four ears, the TM surface remained relatively unobstructed, allowing a date of apparent closure to be established. However, histologic study later revealed that all these perforations were incompletely healed. As illustrated in Figure 2 , the perforations were found to be covered by thin wisps of keratin which, in some cases, covered proteinaceous exudate within the perforation. These cases demonstrate that, in our hands, it was not TM perforation with an Eppendorf syringe. The opposite ear was used as a control, with perforation followed by application of 40 microliters of sterile saline. The ear designated for bFGF treatment was alternated between animals. All ears were treated on days one, three and five with freshly prepared bFGF or sterile saline. The operating microscope was used to examine the perforations on an alternate-day basis for the first two weeks. Perforations were considered to be closed when an unobstructed view of the tympanic membrane showed no opening.
At two weeks , five of the experimental animals were sacrificed under deep anesthesia and temporal bones were removed and fixed in 1% paraformaldehyde/2% glutaraldehyde. The middle ear cavities were subsequently opened, exposing the medial side of the tympanic membrane to permit dissection microscope study of the perforation sites at 30x. After several day s in fixative, the speci mens were decalcified in ethylenediaminetetraacetic (EDTA), rinsed in phosphate buffer (pH 7.4), dehydrated in a series of ethanols and embedded in glycol methacrylate (JB-4; Polysciences, Warrington, PA). Sections were cut at a thickness of five microns and stained with toluidine blue for study by light micro scopy.
The second group of five animals was sacrificed at four weeks but otherwise the same protocol was used. Animals in the second group with open perforations at two weeks were followed until closure was apparent by operating microscope observation. On histologic examination. there were no con sistent differences between the treated and control groups at either the two-or four-week surviva l periods. Moderate epidermal hyperplasia was ob served in most specimens. part icularly near the area of injury (Figure 3 ). Epidermal thickness typically dimini shed dramatically in areas of the TM away from the perforation site . Connective tissue hyperplasia was evident in both the subepithelial and submucosal portions of the lamina propria. Again, these changes were most notable near the injured area ( Figures  3 and 4) . Although a few locali zed foci of loosely textured connective tissue were seen, most of the hyperplastic . connective tissue was strikingly compact. dense and highly cellular. The organization of lamina propria connective tissue in these animals was qualitatively unlike that seen in prev ious studies on experimental cholesteatoma in which propylene glycol was applied to the chinchilla middle ear. "
Light microscopy of tympanic membrane sectio ns showed no evidence of skin ingrowth around any of the perforation margins. There were also no instances of papillary ingrowth of skin through intact portions of the TM. and no evidence of cholesteatoma formation was ob served in any of the material included in the study. in rat tympanic membran es. Pe rfor ations treat ed with b FG F closed more quickly than co ntrols and the o ptima l do se of grow th factor was determined to be 400 ng. In a subse q uent study with rats by Mont ain and Ryan ,' the tim e to perforation closure was ob serv ed to be o ne day soone r (six days) in ears treated with a sing lc 400 ng do se o f bFG F than in co ntro ls. Hyp erplasia of all thre e TM layers was noted in both perforated and non-perforat ed areas and spec imens treated with bFG F were thicker than contro ls. Vrabec c t al 5 demon strated so me wha t sim ilar result s with rats after applying bFG F in a series o f three 5 ug dos es to perforated TM s. Epithelial and lamina propria hyp erp lasia occ urred on the non -operated half o f the tympani c membran es in the treatment group. Th e co ntro l ears also had hyp erplasia and abundant den se conn ectiv e tissue, but o nly in the area o f injury. ln this ex pe rime nt, the dose o f bFGF was higher but the tim e to perforati on clo sure was longer than that in the Mondain and Ryan study. In our study, in whi ch bFGF was applied to c hinchilla TM s in a se ries o f thre e doses, the rate o f perforati on closure wa s found to be quit e variable and, in so me cases, c los ure fai led to occ ur by four wee ks. Despite apparent TM heal ing by operating microscop e obse rvatio n, a number of speci me ns were subse q ue ntly found to hav e sma ll, op en perfor ati on s whi ch were obse rve d in hi stolog ic sec-U l travoice, Inc., 11 61 Lancaster I\. c., Berwyn , PI\. 19 12 800-72 1-4848 / \ W \ .utravoi e. 'om Volume 76, Number 8
For more information Circle 139 on Reader Servic e Card tions. These perforations were typically characterized by gaps in the TM filled with proteinaceous debris and covered by strands of keratin. Although we noted a trend toward earlier perforation closure in the bFGF-treated group, the histology results showed that operating microscope observations regarding time of closure were not always reliable. Thus, the trend toward quicker perforation closure in the treated group cannot be considered a definitive finding.
Our experience with this model clearly suggests that caution must be exercised when attempting to judge perforation closure times based on observation of the lateral aspect of the tympanic membrane in living animals. Histologic evaluation is a much more reliable method for determining full closure of a perforation.
Histologic study of tympanic membrane cross-sections revealed no consistent morphological differences between treated and control ears at either two or four weeks after perforation. This may be due to the fact that any differences in thickness and/or cellularity between bFGF-treated and control TMs are best seen within the first few days after perforation; by eight to ten days such differences tend to become less obvious, as has been observed in previous studies with bFGF. 5 In both bFGF-treated and control specimens, the lamina propria of the tympanic membrane was comprised primarily of dense connective tissue in which closely packed fibrocytes were oriented parallel to the surface. This arrangement should provide an effective barrier against ingrowth of skin toward the middle ear cavity and, in fact, no papillary ingrowth of epidermis nor evidence of cholesteatoma formation was observed in any of the specimens. The densely organized connective tissue found to occupy the lamina propria was quite unlike that noted in previous studies following the introduction of irritants such as propylene glycol into the chinchilla middle ear. 8 • 9 In that case, loose, highly vascular connective tissue fills the middle layer of the TM, providing a granulation tissuelike medium that appears to encourage ingrowth of epidermis and subsequent cholesteatoma formation, which typically occurs two to four weeks after propylene glycol application.
Although our study is inconclusive with regard to the effectiveness of basic FGF on tympanic membrane healing, or the ultimate impact ofbFGF on the ultrastructure of the human tympanic membrane, one consistent finding in all bFGF studies has been the lack of cholesteatoma formation. Given the four-week survival period used in this investigation, it would seem that the risk of cholesteatoma development following administration of bFGF is minimal when it is applied short-term to acute perforations.
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Summary
Basic fibroblast growth factor (bFGF) is a polypeptide mitogen which stimulates proliferation of epidermal and connective tissue cells. When applied to tympanic membrane perforations it has been reported to enhance healing and produce connective tissue hyperplasia. Previous work with animal models has shown that hyperplastic alterations of the tympanic membrane play an essential role in cholesteatoma development. This study was designed to further investigate the hyperplastic effects ofbFGF and to determine if it might induce cholesteatoma formation during the healing process.
Ten chinchillas received bilateral tympanic membrane perforations. In each animal, three doses of bFGF (400 nanograms per dose) were applied to the perforated tympanic membrane on one side; the opposite (control) ear received saline alone. The animals were terminated at either two or four weeks and studied histologically.
Although the dosage and administration schedule used were consistent with previous studies utilizing other rodent species, there was little evidence that bFGF affected tympanic membrane healing in chinchillas. In both control and bFGF-treated ears, dense connective tissue occupied the lamina propria of the tympanic membrane, providing an effective barrier against ingrowth of skin toward the middle ear. No cholesteatomas developed in any animals included in the study.
The results of this work indicate that the risk of cholesteatoma formation following administration of bFGF is minimal when it is applied short-term to acute perforations.
